Mark Dybul - 13 Feb 2024 Form 4 Insider Report for RENOVARO BIOSCIENCES INC. (RENB)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
16 Feb 2024, 09:06:47 UTC
Prior SEC filing
15 Sep 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Mark Dybul

Key filing fact

Mark Dybul filed Form 4 for RENOVARO BIOSCIENCES INC. (RENB) on 16 Feb 2024.

Key facts

  • This page summarizes Mark Dybul's Form 4 filing for RENOVARO BIOSCIENCES INC. (RENB).
  • 12 reported transactions and 12 derivative rows are listed below.
  • Accepted by SEC: 16 Feb 2024, 09:06.

Change

  • Previous filing in this sequence was filed on 15 Sep 2022.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

RENB transaction Derivative

Option to Purchase Common Stock

Disposed to Issuer

Transaction value
Shares
-7,563
Change %
-100%
Price
Shares after
0
Date
13 Feb 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
7,563
Exercise price
$5.95
Footnotes
F1, F2
RENB transaction Derivative

Option to Purchase Common Stock

Award

Transaction value
Shares
+7,563
Change %
Price
Shares after
7,563
Date
13 Feb 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
7,563
Exercise price
$1.92
Footnotes
F2
RENB transaction Derivative

Option to Purchase Common Stock

Disposed to Issuer

Transaction value
Shares
-5,226
Change %
-100%
Price
Shares after
0
Date
13 Feb 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
5,226
Exercise price
$5.74
Footnotes
F2
RENB transaction Derivative

Option to Purchase Common Stock

Award

Transaction value
Shares
+5,226
Change %
Price
Shares after
5,226
Date
13 Feb 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
5,226
Exercise price
$1.92
Footnotes
F2
RENB transaction Derivative

Option to Purchase Common Stock

Disposed to Issuer

Transaction value
Shares
-300,000
Change %
-100%
Price
Shares after
0
Date
13 Feb 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
300,000
Exercise price
$6.50
Footnotes
F2
RENB transaction Derivative

Option to Purchase Common Stock

Award

Transaction value
Shares
+300,000
Change %
Price
Shares after
300,000
Date
13 Feb 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
300,000
Exercise price
$1.92
Footnotes
F2
RENB transaction Derivative

Option to Purchase Common Stock

Disposed to Issuer

Transaction value
Shares
-450,000
Change %
-100%
Price
Shares after
0
Date
13 Feb 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
450,000
Exercise price
$8.00
Footnotes
F2
RENB transaction Derivative

Option to Purchase Common Stock

Award

Transaction value
Shares
+450,000
Change %
Price
Shares after
450,000
Date
13 Feb 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
450,000
Exercise price
$1.92
Footnotes
F2
RENB transaction Derivative

Option to Purchase Common Stock

Disposed to Issuer

Transaction value
Shares
-2,000,000
Change %
-100%
Price
Shares after
0
Date
13 Feb 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,000,000
Exercise price
$4.57
Footnotes
F2, F3
RENB transaction Derivative

Option to Purchase Common Stock

Award

Transaction value
Shares
+2,000,000
Change %
Price
Shares after
2,000,000
Date
13 Feb 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,000,000
Exercise price
$1.92
Footnotes
F2, F3
RENB transaction Derivative

Option to Purchase Common Stock

Disposed to Issuer

Transaction value
Shares
-350,000
Change %
-100%
Price
Shares after
0
Date
13 Feb 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
350,000
Exercise price
$2.54
Footnotes
F2, F4
RENB transaction Derivative

Option to Purchase Common Stock

Award

Transaction value
Shares
+350,000
Change %
Price
Shares after
350,000
Date
13 Feb 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
350,000
Exercise price
$1.92
Footnotes
F2, F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

The option vested in three equal installments on February 28, 2019, February 28, 2020 and February 28, 2021.

Footnote F2

The transactions reported herein reflect a stock option repricing (the "Option Repricing") effective on February 13, 2024 (the "Repricing Date"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the "Common Stock"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options.

Footnote F3

The option vested in two equal installments on July 1, 2022 and July 1, 2023. The remainder of the option vests on July 1, 2024.

Footnote F4

One third of the option vested on August 25, 2023. The remainder of the option shall vest in two equal installments on August 25, 2024 and August 25, 2025.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .